Manufacturer's investigation conclusion: a direct correlation between the centrimag blood pump and the reported events could not conclusively be established through this evaluation.Although a specific cause for the reported myocardical infarction could not be determined through this evaluation, it was reported by the account that the patient's death was not considered to be device-related, and that the device operated as expected.The device will not be returned for evaluation.Multiple requests for additional information, including the lot number of the device, have been sent to the customer; however, no response has been received at this time.Centrimag blood pump instructions for use (ifu) was released in (b)(6) 2019.Death and myocardial infarction are listed as adverse events that may be associated with the use on the centrimag ventricular assist device (vad).It also contains the following warnings and precautions: ifu warning #1: carefully read all warnings, precautions, manuals, and instructions for use for this and all related thoratec extracorporeal devices prior to use.Failure to read and follow all instruction, or failure to observe all stated warnings, could cause serious injury or death to the patient.No further information was provided.The manufacturer is closing the file on this event.
|